AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
9.34
-0.19 (-1.99%)
Dec 30, 2024, 12:09 PM EST - Market open
AdaptHealth Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for AdaptHealth stock have an average target of 12.4, with a low estimate of 11 and a high estimate of 14. The average target predicts an increase of 32.76% from the current stock price of 9.34.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 19, 2024.
Analyst Ratings
The average analyst rating for AdaptHealth stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 2 | 1 | 1 | 1 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $13 → $11 | Buy | Maintains | $13 → $11 | +17.77% | Nov 19, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +28.48% | Nov 15, 2024 |
| UBS | UBS | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +28.48% | Nov 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +39.19% | Nov 6, 2024 |
| Baird | Baird | Buy Maintains $16 → $14 | Buy | Maintains | $16 → $14 | +49.89% | Nov 6, 2024 |
Financial Forecast
Revenue This Year
3.30B
from 3.20B
Increased by 3.06%
Revenue Next Year
3.39B
from 3.30B
Increased by 2.91%
EPS This Year
0.54
from -5.31
EPS Next Year
0.87
from 0.54
Increased by 61.60%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.4B | 3.6B | 3.9B |
| Avg | 3.3B | 3.4B | 3.6B |
| Low | 3.2B | 3.2B | 3.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 6.4% | 9.0% | 16.1% |
| Avg | 3.1% | 2.9% | 5.6% |
| Low | -1.4% | -2.6% | -2.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.63 | 1.19 | 1.46 | ||
| Avg | 0.54 | 0.87 | 1.07 | ||
| Low | 0.45 | 0.67 | 0.69 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 121.1% | 68.3% | ||
| Avg | - | 61.6% | 23.2% | ||
| Low | - | 24.2% | -20.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.